HAMPTON, N.J., Aug. 02, 2016 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (Nasdaq:CLDX) will release second
quarter 2016 financial results on Monday, August 8, 2016 after the U.S. financial markets close. Celldex executives will host a
conference call at 4:30 p.m. EDT on the same day to review the second quarter 2016 financial results and to provide an update on
key research and development and business objectives for the remainder of 2016.
The conference call and presentation will be webcast live over the Internet and can be accessed by going to the "Events &
Presentations" page under the "Investors & Media" section of the Celldex Therapeutics website at www.celldex.com. The call can also be accessed by dialing (866) 743-9666 (within the United
States) or (760) 298-5103 (outside the United States). The passcode is 53265640.
A replay of the call will be available approximately two hours after the live call concludes through August 15, 2016. To access
the replay, dial (855) 859-2056 (within the United States) or (404) 537-3406 (outside the United States). The passcode is 53265640.
The webcast will also be archived on the Company's website.
About Celldex Therapeutics, Inc.
Celldex is developing targeted therapeutics to address devastating diseases for which available treatments are inadequate. Our
pipeline is built from a proprietary portfolio of antibodies and immunomodulators used alone and in strategic combinations to
create novel, disease-specific therapies that induce, enhance or suppress the body's immune response. Visit www.celldex.com.
Contact: Sarah Cavanaugh Vice President of Investor Relations & Corp Communications Celldex Therapeutics, Inc. (781) 433-3161 scavanaugh@celldex.com Charles Liles Associate Director of Investor Relations & Corp Communications Celldex Therapeutics, Inc. (781) 433-3107 cliles@celldex.com
